ABSTRACT Bronchial responsiveness (histamine PC2o) and peripheral blood eosinophil counts were measured in 23 asthmatic subjects, of whom 14 were atopic and nine non-atopic. In the group as a whole there was an inverse correlation between baseline eosinophil count and histamine PC20 (r = -0O71; p < 0001). For atopic subjects a relationship between eosinophil count and histamine PC 20 was observed (r = -0 74; p < 0 01), but there was no correlation between eosinophil count and baseline FEV1 or baseline FEV1 and histamine PC20. For the non-atopic subjects a similar relationship between eosinophil count and histamine PC20 was seen (r = -0-68; p < 0-05) and a less significant inverse correlation between baseline eosinophil count and baseline FEV, (r = 0-65; p < 0-05). These results show a relationship between eosinophil count and non-specific bronchial responsiveness in both atopic and non-atopic asthma.
Eosinophilia in association with reversible airways obstruction has been recognised since the early 1900s but the precise role of the eosinophil has not been fully established. It appears to have the potential for a dual role, on the one hand releasing enzymes capable of degrading mast cell mediators and modulating their effects' but on the other contributing to tissue damage by deposition of major basic protein in the bronchi. 2 In patients with stable asthma the peripheral blood eosinophil count shows wide variation3 and eosinophilia does not differentiate atopic from non-atopic asthma. In non-atopic asthma a relationship between the peripheral blood eosinophil count and the FEV1 has been observed and the eosinophil count shown to be useful in monitoring disease activity.4 In addition, a relationship between eosinophil count and methacholine PC20 has been observed in subjects with allergen induced late phase asthmatic reactions. 5 We have investigated the relationship between the peripheral blood eosinophil count and bronchial responsiveness determined by histamine challenge in subjects with atopic and non-atopic asthma. Venous blood was taken just before histamine challenge testing and put into a tube containing EDTA. Eosinophil counts were performed with a FuchsRosenthal counting chamber.8 The EDTA blood was added to diluting fluid containing 10 ml aqueous eosin (200 g/l), 10 ml acetone, and 80 ml distilled water to obtain a 1:20 dilution. The suspension was mixed for 30 seconds and added to the counting chamber. The total number of eosinophils within the ruled area was counted and at least four chambers were counted. The results were expressed as total eosinophils per litre. Counts were performed by one observer without knowledge of the patient's histamine PC20. The coefficient of variation for eosinophil counts obtained by this method was consistently less than 10%.
STATISTICAL METHODS
Natural logarithmic transformations were applied to all histamine PC20 values before analysis. Correlation coefficients were calculated by use of linear regression analysis by the method of least squares.
Results
Individual eosinophil counts and histamine PC20 values are shown in the table. There was a wide range of histamine PC20 values, ranging from 0-03 to 13-5 mg/ml for atopic subjects and from 0-03 to 15-0 mg/ml for non-atopic subjects. Similarly, the eosinophil count showed wide variation, with a mean value of 383 (range 55-915) x 106/1 for the atopic subjects and 310 (range 30-690) x 106/1 for the nonatopic subjects. The mean FEV1 was 84% predicted 454 (range 60-112%) for the atopic subjects and 79% (range 50-107%) for the non-atopic subjects. There was a significant inverse correlation between baseline eosinophil count and log histamine PC20.
For all 23 subjects, r = -0-71 (p < 0-001); for the 14 atopic subjects, r = -0-74 (p < 0-01); for the nine non-atopic subjects, r = -0O68 (p < 0-05), see figure 1. There was an inverse correlation between baseline eosinophil count and baseline FEV1 in the non-atopic subjects (r = -0-65; p < 005) but no such correlation in the atopic group (fig 2) . There was no correlation between baseline FEV, and histamine PC20 for either group and no correlation between age and histamine PC20 or age and eosinophil count. The presence of eosinophils in the peripheral blood may not reflect what is happening at other sites directly but eosinophils were found to be prominent in bronchoalveolar lavage fluid from patients with mild asthma.'4 In a previous study by one of the authors, in which blood eosinophil counts were examined in different clinical patterns of asthma,3 blood eosinophilia was almost invariable in chronic worsening asthma, a condition in which increased bronchial reactivity would be expected. Paradoxically, acute severe asthma was associated with blood eosinopenia, possibly because it provoked a stress response with increased cortisol secretion.'5 Adrenal corticosteroids are a potent cause of eosinopenia; four hours after a 100 mg dose of hydrocortisone eosinophils were almost absent from peripheral blood. 16 An association between the peripheral blood eosinophil count and the level of bronchial responsiveness after methacholine has been shown in subjects who developed an allergen induced late phase reaction, and the eosinophil count increased 24 hours after challenge in these subjects.5 Our findings are consistent with the initial observations in this study. Total eosinophil counts correlated inversely with FEV, in systemic steroid dependent non-atopic asthma in one study, in keeping with our observations, though our non-atopic subjects were not taking systemic steroids. Smoking has been shown to increase both bronchial responsiveness,'7 and absolute eosinophil count,'8 but since only three of our subjects were current smokers (table), this factor is unlikely to have confounded our results.
A reduction in eosinophil count might be expected to have some beneficial effect on disease activity, either directly or indirectly; and indeed one effect of systemic corticosteroid treatment is a reduction in eosinophil count. 4 The effect of systemic corticosteroid treatment on bronchial responsiveness, however, is not fully established, and studies have shown conflicting results.'9 2' A recent study of subjects with stable asthma showed that methylprednisolone protected against increased bronchial responsiveness to carbachol, but the effect on eosinophil count was not determined. 22 Treatment with either inhaled sodium cromoglycate23 or inhaled cortiscosteroid2425 produces a small reduction in bronchial responsiveness. Our subjects who were having regular treatment with these agents continued to take them and a similar proportion of treated and untreated subjects were present in the two groups (table) . When data on these treated subjects were excluded from the analysis, the same relationship between eosinophil count and bronchial responsiveness was apparent.
We conclude that there is a relationship between the peripheral blood eosinophil count and nonspecific bronchial responsiveness in both atopic and non-atopic asthma.
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